Quantinuum (NASDAQ:QNT) Shares Gap Up – What’s Next?

Quantinuum Inc. (NASDAQ:QNT – Get Free Report)’s stock price gapped up before the market opened on Monday. The stock had previously closed at $36.55, but opened at $38.78. Quantinuum shares last traded at $37.37, with a volume of 519,108 shares traded.

Quantinuum News Summary

Here are the key news stories impacting Quantinuum this week:

  • Positive Sentiment: Quantinuum’s Helios system achieved 99.9995% logical fidelity—only five errors per million operations. The error rate is reportedly 10 times better than the company’s September result and 100 times below the best published result from other hardware approaches, strengthening its case for fault-tolerant quantum computing. Quantinuum Breaks Error-Correction World Record by 10x
  • Positive Sentiment: The milestone makes Quantinuum’s goal of developing a fault-tolerant Apollo system by 2029 appear more credible. Its architecture may require substantially fewer physical qubits—potentially lowering manufacturing, cooling and scaling costs compared with competing technologies. Quantinuum Sees Path to Fault-Tolerant Quantum Computing by 2029
  • Positive Sentiment: Analysts see a potential valuation disconnect. Morgan Stanley has an Overweight rating and a $62 price target, while the broader consensus target is reportedly around $94. Quantinuum also holds approximately $2.1 billion in cash, providing funding for development without immediate dependence on capital markets. Could Quantinuum’s Breakthrough Make Its Sell-Off a Bargain?
  • Neutral Sentiment: Revenue growth is reportedly strong, up roughly 279% year over year, but the latest quarter generated only $8 million of revenue. Quantinuum also reported a $0.28 per-share loss, slightly worse than the $0.26 consensus estimate, underscoring that commercialization and profitability remain distant.
  • Negative Sentiment: Shares have fallen sharply over the past three months and remain close to the 52-week low. Investors continue to face significant execution risk as Quantinuum must scale Helios, launch its planned Sol system and translate technical advances into recurring commercial revenue. Has Quantinuum Fallen Enough to Trade Below Fair Value?

Wall Street Analyst Weigh In

Several research firms have recently weighed in on QNT. Bank of America began coverage on shares of Quantinuum in a research note on Monday, June 29th. They set a “buy” rating and a $100.00 price target for the company. UBS Group assumed coverage on Quantinuum in a research note on Monday, June 29th. They issued a “buy” rating and a $93.00 price objective on the stock. Yorkville Ives started coverage on Quantinuum in a research note on Monday, October 5th. They issued an “outperform” rating and a $60.00 price objective on the stock. Morgan Stanley upgraded Quantinuum from an “equal weight” rating to an “overweight” rating and reduced their price objective for the stock from $78.00 to $62.00 in a report on Thursday, October 15th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $90.00 target price on shares of Quantinuum in a research report on Wednesday, August 12th. Thirteen investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Quantinuum has a consensus rating of “Moderate Buy” and a consensus target price of $94.23.

Read Our Latest Report on QNT

Quantinuum Price Performance

The company’s fifty day moving average price is $49.36. The stock has a market cap of $9.39 billion and a PE ratio of -127.43.

Quantinuum (NASDAQ:QNT – Get Free Report) last issued its earnings results on Tuesday, August 11th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.26) by ($0.02). The business had revenue of $8.00 million for the quarter. As a group, equities research analysts anticipate that Quantinuum Inc. will post -4.76 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Quantinuum

Hedge funds and other institutional investors have recently modified their holdings of the business. IFP Advisors Inc increased its holdings in Quantinuum by 1,150.0% during the third quarter. IFP Advisors Inc now owns 1,250 shares of the company’s stock valued at $60,000 after buying an additional 1,150 shares during the period. Counterpoint Mutual Funds LLC bought a new position in Quantinuum in the third quarter worth approximately $408,000. Vontobel Holding Ltd. purchased a new stake in Quantinuum during the third quarter worth $743,000. Parisi Gray Wealth Management lifted its holdings in Quantinuum by 508.7% during the third quarter. Parisi Gray Wealth Management now owns 18,717 shares of the company’s stock worth $900,000 after buying an additional 15,642 shares during the period. Finally, Steel Grove Capital Advisors LLC lifted its holdings in Quantinuum by 25.6% during the third quarter. Steel Grove Capital Advisors LLC now owns 5,992 shares of the company’s stock worth $288,000 after buying an additional 1,222 shares during the period.

Quantinuum Company Profile

(Get Free Report)

Quantinuum is a quantum computing company formed in 2021 through the combination of Honeywell Quantum Solutions and Cambridge Quantum. The company develops full-stack quantum computing technologies designed to support research and commercial applications across industries, including chemistry, materials science, cybersecurity, finance and artificial intelligence.

Its offerings include trapped-ion quantum computers, quantum software and development tools. Quantinuum’s software portfolio includes the TKET quantum compiler, InQuanto quantum chemistry platform, Quantum Origin quantum-enhanced cybersecurity solutions and the Nexus platform for developing and managing quantum applications.

Read More

Receive News & Ratings for Quantinuum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantinuum and related companies with MarketBeat.com's FREE daily email newsletter.